Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control.
Petrongari MG, Landoni V, Saracino B, Gomellini S, Arcangeli S, Iaccarino G, Pinnarò P, Arcangeli G, Strigari L. Petrongari MG, et al. Among authors: gomellini s. J Exp Clin Cancer Res. 2013 Dec 13;32(1):103. doi: 10.1186/1756-9966-32-103. J Exp Clin Cancer Res. 2013. PMID: 24330467 Free PMC article. Clinical Trial.
Long-Term Outcomes of Once-Daily Accelerated Partial-Breast Irradiation With Tomotherapy: Results of a Phase 2 Trial.
de Paula U, D'Angelillo RM, Andrulli AD, Apicella G, Caruso C, Ghini C, Gomellini S, Ponti E, Pompei M, Caccavari A, Petrocchi A, Costarelli L, Giordano M, La Pinta M, Meli EZ, Mauri M, Minelli M, Rossi R, Scavina P, Broglia L, Ponzani T, Loreti A, Fortunato L. de Paula U, et al. Among authors: gomellini s. Int J Radiat Oncol Biol Phys. 2021 Mar 1;109(3):678-687. doi: 10.1016/j.ijrobp.2020.10.009. Epub 2020 Oct 21. Int J Radiat Oncol Biol Phys. 2021. PMID: 33098960 Free article. Clinical Trial.
Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
Arcangeli S, Saracino B, Petrongari MG, Gomellini S, Marzi S, Landoni V, Gallucci M, Sperduti I, Arcangeli G. Arcangeli S, et al. Among authors: gomellini s. Radiother Oncol. 2007 Aug;84(2):148-55. doi: 10.1016/j.radonc.2007.06.011. Epub 2007 Aug 9. Radiother Oncol. 2007. PMID: 17692416
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer.
Arcangeli G, Fowler J, Gomellini S, Arcangeli S, Saracino B, Petrongari MG, Benassi M, Strigari L. Arcangeli G, et al. Among authors: gomellini s. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1013-21. doi: 10.1016/j.ijrobp.2009.12.045. Epub 2010 May 5. Int J Radiat Oncol Biol Phys. 2011. PMID: 20447774 Clinical Trial.
19 results